| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.3B | $20.7B | $20.5B | $19.2B | $19.5B | $4.9B | $4.8B | $4.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.5B | $6.0B | $2.5B | $2.3B | $2.9B | $2.0B | $1.5B | $1.6B |
| Net Income | $2.4B | $4.1B | $1.3B | $1.0B | $1.5B | $0.5B | $0.1B | $0.1B |
| EPS (Basic) | $15.61 | $33.02 | $6.01 | $3.84 | $8.55 | $3.92 | $0.02 | $-0.04 |
| EPS (Diluted) | $15.49 | $32.70 | $5.71 | $3.79 | $8.42 | $3.86 | $0.02 | $-0.04 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.7B | $28.9B | $28.3B | $27.2B | $27.6B | $27.1B | $23.4B | $22.4B |
| Current Assets | $7.8B | $7.7B | $7.2B | $6.0B | $7.1B | $7.1B | $5.1B | $4.6B |
| Cash & Equivalents | $2.9B | $3.0B | $1.2B | $0.9B | $2.4B | $2.4B | $0.3B | $0.4B |
| Total Liabilities | $20.7B | $20.4B | $22.8B | $22.5B | $23.3B | $24.2B | $21.4B | $20.3B |
| Current Liabilities | $4.5B | $4.3B | $4.8B | $4.5B | $5.1B | $4.8B | $4.2B | $3.9B |
| Stockholders' Equity | $4.2B | $4.2B | $1.6B | $1.1B | $1.0B | $0.0B | $-0.4B | $-0.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.5B | $2.0B | $2.4B | $1.1B | $1.6B | $3.4B | $1.2B | $1.0B |
| Investing Cash Flow | $-1.3B | $3.4B | $-1.0B | $-0.8B | $-0.7B | $-1.6B | $-0.6B | $-0.1B |
| Capital Expenditures | $1.0B | $0.9B | $0.8B | $0.8B | $0.7B | $0.5B | $0.7B | $0.6B |
| Financing Cash Flow | $-2.4B | $-3.7B | $-1.0B | $-1.8B | $-0.9B | $0.4B | $-0.8B | $-1.1B |